|
Model Number SYM1510OS |
Device Problems
Migration or Expulsion of Device (1395); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Adhesion(s) (1695); Anemia (1706); Cyst(s) (1800); Hematoma (1884); Nausea (1970); Pain (1994); Scarring (2061); Injury (2348); Deformity/ Disfigurement (2360); Disability (2371); Blood Loss (2597); No Code Available (3191)
|
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after implant, the patient experienced severe adhesions, bowel adhesion, mesh "rolled-up", severe pain, inability to work, partial excision, fascia debridement, nausea, scarring and disfigurement.Treatment provided for these conditions include surgical revision of the mesh.
|
|
Manufacturer Narrative
|
This information was received as a part of an extensive mesh litigation submission to medtronic.The fda was notified of this large complaint receipt.Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced severe adhesions, bowel adhesion, mesh "rolled-up", abdominal wall hematoma, chronic acute blood loss, anemia, bilateral simple renal cyst, severe pain, inability to work, nausea, scarring and disfigurement.Post-operative patient treatment included revision surgery, partial excision, fascia debridement, consider repeat ultrasound in 6-12 months and monitoring kidney function.
|
|
Event Description
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced severe adhesions, bowel adhesion, mesh "rolled-up", abdominal wall hematoma, chronic acute blood loss, anemia, bilateral simple renal cyst, severe pain, inability to work, nausea, scarring, mass, pelvic free fluid and disfigurement.Post-operative patient treatment included revision surgery, partial excision, fascia debridement, consider repeat ultrasound in 6-12 months and monitoring kidney function.
|
|
Manufacturer Narrative
|
This information was received as a part of an extensive mesh litigation submission to medtronic.The fda was notified of this large complaint receipt.Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|